BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36040265)

  • 1. The gateway to guanine nucleotides: Allosteric regulation of IMP dehydrogenases.
    Buey RM; Fernández-Justel D; Jiménez A; Revuelta JL
    Protein Sci; 2022 Sep; 31(9):e4399. PubMed ID: 36040265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of mechanisms to control bacterial GTP homeostasis by the mutually exclusive binding of adenine and guanine nucleotides to IMP dehydrogenase.
    Fernández-Justel D; Marcos-Alcalde Í; Abascal F; Vidaña N; Gómez-Puertas P; Jiménez A; Revuelta JL; Buey RM
    Protein Sci; 2022 May; 31(5):e4314. PubMed ID: 35481629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.
    Fernández-Justel D; Núñez R; Martín-Benito J; Jimeno D; González-López A; Soriano EM; Revuelta JL; Buey RM
    J Mol Biol; 2019 Mar; 431(5):956-969. PubMed ID: 30664871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased riboflavin production by manipulation of inosine 5'-monophosphate dehydrogenase in Ashbya gossypii.
    Buey RM; Ledesma-Amaro R; Balsera M; de Pereda JM; Revuelta JL
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9577-89. PubMed ID: 26150243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bateman domain of IMP dehydrogenase is a binding target for dinucleoside polyphosphates.
    Fernández-Justel D; Peláez R; Revuelta JL; Buey RM
    J Biol Chem; 2019 Oct; 294(40):14768-14775. PubMed ID: 31416831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
    McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
    Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMPDH dysregulation in disease: a mini review.
    Burrell AL; Kollman JM
    Biochem Soc Trans; 2022 Feb; 50(1):71-82. PubMed ID: 35191957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.
    Buey RM; Fernández-Justel D; Marcos-Alcalde Í; Winter G; Gómez-Puertas P; de Pereda JM; Luis Revuelta J
    Sci Rep; 2017 Jun; 7(1):2648. PubMed ID: 28572600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation.
    Johnson MC; Kollman JM
    Elife; 2020 Jan; 9():. PubMed ID: 31999252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
    Liu FY; Qiu XY; Jiao Z
    Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
    Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
    Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.
    Buey RM; Ledesma-Amaro R; Velázquez-Campoy A; Balsera M; Chagoyen M; de Pereda JM; Revuelta JL
    Nat Commun; 2015 Nov; 6():8923. PubMed ID: 26558346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Sintchak MD; Nimmesgern E
    Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory role of the Bateman domain of IMP dehydrogenase in adenylate nucleotide biosynthesis.
    Pimkin M; Pimkina J; Markham GD
    J Biol Chem; 2009 Mar; 284(12):7960-9. PubMed ID: 19153081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA UCA1 Participates in De Novo Synthesis of Guanine Nucleotides in Bladder Cancer by Recruiting TWIST1 to Increase IMPDH1/2.
    Liu SS; Li JS; Xue M; Wu WJ; Li X; Chen W
    Int J Biol Sci; 2023; 19(8):2599-2612. PubMed ID: 37215997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
    Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS
    Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent inactivation of Mycobacterium thermoresistibile inosine-5'-monophosphate dehydrogenase (IMPDH).
    Trapero A; Pacitto A; Chan DS; Abell C; Blundell TL; Ascher DB; Coyne AG
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126792. PubMed ID: 31757668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The basic functions of inosine 5'-monophosphate dehydrogenase and its application in drug discovery].
    Zhang YW; Zhang D; Sun H
    Yao Xue Xue Bao; 2014 Mar; 49(3):285-92. PubMed ID: 24961097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
    Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
    PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
    Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
    Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.